Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up

Last updated: January 24, 2024
Sponsor: Waldemar Link GmbH & Co. KG
Overall Status: Active - Recruiting

Phase

N/A

Condition

Osteoarthritis

Treatment

MobileLink

Clinical Study ID

NCT04688593
HP15
  • Ages > 18
  • All Genders

Study Summary

The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results.

The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Implantation of a MobileLink acetabular cup system and a femoral stem manufactured byWaldemar Link
  • Age ≥ 18 years
  • Fully signed patient informed cons

Exclusion

Exclusion Criteria:

  • Revisions
  • Body Mass Index (BMI) ≥ 40 kg/m²
  • Patient who is foreseeable not able to understand the study and the study-relatedcircumstances
  • Patients who is foreseeable non-compliant to the treatment and the follow-ups
  • Pregnant or breast-feeding women
  • Prisoner

Study Design

Total Participants: 520
Treatment Group(s): 1
Primary Treatment: MobileLink
Phase:
Study Start date:
May 04, 2021
Estimated Completion Date:
January 31, 2036

Connect with a study center

  • Orthopädische Klinik

    Hessisch Lichtenau,
    Germany

    Site Not Available

  • Lubinus Stiftung

    Kiel,
    Germany

    Active - Recruiting

  • NHS FIFE Victoria Hospital

    Kirkcaldy,
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.